Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts
نویسندگان
چکیده
منابع مشابه
Taking Renin-Angiotensin Drugs in Patients with COVID-19: Start, Continue, or Stop; a Literature Review
Considering the pandemic of the COVID-19 disease, the use of various drugs in patients has been investigated. Recently, numerous studies have been done on the effectiveness of drugs which used to treat the underlying disease such as congestive heart failure, hypertension, as well as coronary artery disease in various countries, because the patients with underlying conditions are more likely ...
متن کاملRenin-angiotensin system and unilateral ureteral obstruction
Unilateral ureteral obstruction (UUO) is a clinical scenario that leads to obstructive nephropathy. UUO alters the expression of many mediators in the ipsilateral kidney. Renin-angiotensin system (RAS) is involved in UUO. Angiotensin II (Ang II) and angiotensin 1-7 (Ang 1-7) as the main arms of RAS influence kidney function which may alter by UUO. Ang II via Ang II receptor subtypes I (AT1R) ...
متن کاملInhibitors of the renin-angiotensin system in established cardiac failure.
Congestive heart failure is a common clinical syndrome and recent epidemiologic surveys indicate that its incidence is increasing. It has been estimated that as many as four million people may suffer from heart failure in the United States.' In the United Kingdom, the estimated prevalence is 3 9 per 1000 patients, and worldwide over 15 million patients are thought to have heart failure.2 The ra...
متن کاملTherapeutic effect of renin angiotensin system inhibitors on liver fibrosis
BACKGROUND AND OBJECTIVE Currently, there is no effective therapy available for liver fibrosis. This study aims to evaluate the efficacy of renin angiotensin system inhibitors on liver fibrosis. METHOD Full-text randomized controlled trials in patients with liver fibrosis were identified and included in the meta-analysis. The primary outcome measure was the histological fibrosis score of the ...
متن کاملPotassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Inhibition of the renin-angiotensin-aldosterone system (RAAS) is a key strategy in treating hypertension and cardiovascular and renal diseases. However, RAAS inhibitors (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone receptor antagonists, and direct renin inhibitors) increase the risk of hyperkalemia (serum potassium >5.5 mmol/L). This review evaluates the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Hypertension
سال: 2020
ISSN: 2090-0392,2090-0384
DOI: 10.1155/2020/1025913